Showing 17,841 - 17,860 results of 36,238 for search '(( 50 ((ng decrease) OR (((a decrease) OR (mean decrease)))) ) OR ( 2 de decrease ))', query time: 1.18s Refine Results
  1. 17841

    Table 1_The impact of environmental and health messaging, pulse prevalence, and filtering tools on pulse-based food choice and nutrient profiles: a randomized online experiment.doc... by Christopher R. Gustafson (6077870)

    Published 2025
    “…The choice environment featured six food categories containing 50 products each. The intervention arms examined: (1) the proportion of pulse foods in the choice environment (10% vs. 20%), enhancing awareness of the benefits of pulses at the point of decision (health and/or environmental messaging), and reducing search costs for pulse products in complex retail environments via a pulse filter. …”
  2. 17842

    Image_2_A Label-Free Quantitative Proteomic Analysis of Mouse Neutrophil Extracellular Trap Formation Induced by Streptococcus suis or Phorbol Myristate Acetate (PMA).PDF by Xiaoping Wang (110673)

    Published 2018
    “…In the present study, we used a label-free quantitative proteomic analysis of mouse NET formation induced by S. suis or phorbol myristate acetate (PMA), a robust NET inducer. …”
  3. 17843

    DataSheet_1_Overexpression of Maize ZmMYB59 Gene Plays a Negative Regulatory Role in Seed Germination in Nicotiana tabacum and Oryza sativa.doc by Kaihui Zhai (9364637)

    Published 2020
    “…In T<sub>2</sub> generation transgenic tobacco, germination rate, germination index, vigor index and hypocotyl length were significantly decreased by 25.0–50.9, 34.5–54.4, 57.5–88.3, and 21.9–31.3% compared to wild-type (WT) lines. …”
  4. 17844

    Associations of cognitive impairment and functional limitation with all-cause mortality risk in older adults: A population-based study from the National Health and Nutrition Examin... by Wenxiu Zhu (12572745)

    Published 2024
    “…Cognitive impairment and functional limitation independently correlated with all-cause mortality risk even after adjusting for covariates and performing mutual adjustments (HR for cognitive impairment: 1.34, 95% CI 1.15–1.56; HR for functional limitation: 1.50, 95% CI 1.32–1.70). When the DSC score was > 18, as the score increased, the risk of death significantly decreased (HR 0.99, 95% CI 0.98–0.99). …”
  5. 17845

    Image_1_A Label-Free Quantitative Proteomic Analysis of Mouse Neutrophil Extracellular Trap Formation Induced by Streptococcus suis or Phorbol Myristate Acetate (PMA).PDF by Xiaoping Wang (110673)

    Published 2018
    “…In the present study, we used a label-free quantitative proteomic analysis of mouse NET formation induced by S. suis or phorbol myristate acetate (PMA), a robust NET inducer. …”
  6. 17846

    Table 5_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.pdf by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  7. 17847

    Table 1_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.docx by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  8. 17848

    Table 3_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.docx by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  9. 17849

    Table 4_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.pdf by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  10. 17850

    Table 2_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.docx by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  11. 17851

    Image 2_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.jpeg by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  12. 17852

    Image 3_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.jpeg by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  13. 17853

    Image 1_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.jpeg by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  14. 17854

    Targeting Ruminative Thinking in Adolescents at Risk for Depressive Relapse: Rumination-Focused Cognitive Behavior Therapy in a Pilot Randomized Controlled Trial with Resting State... by Rachel H. Jacobs (622107)

    Published 2016
    “…</p><p><b><i>Trial Registration</i>:</b> ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT01905267" target="_blank">NCT01905267</a></p></div>…”
  15. 17855

    Table_1_Estrogen Protects Neurotransmission Transcriptome During Status Epilepticus.XLSX by Dumitru A. Iacobas (5423981)

    Published 2018
    “…<p>Women with epilepsy commonly have premature onset of menopause. The decrease in estrogen levels is associated with increased occurrence of neurodegenerative processes and cognitive decline. …”
  16. 17856

    <i>Rps6</i>-deficiency induces p53 and disrupts rRNA processing. by Sarah A. Comerford (3854917)

    Published 2023
    “…Original magnifications; a, d, e (x 125; scale bars, 50μ); b, c, f, g (x 250; scale bars, 25μ). …”
  17. 17857

    Presentation_1_Enhancement of Silymarin Anti-fibrotic Effects by Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) β-Cyclodextrins in a Mouse Model of Liver F... by Sami Gharbia (5623040)

    Published 2018
    “…Experimental fibrosis was induced by intraperitoneal injection with 2 ml/kg CCl<sub>4</sub> (20% v/v) twice a week, for 7 weeks. Mice were orally treated with 50 mg/kg of Sy-HPBCD, Sy-RAMEB and free silymarin. …”
  18. 17858
  19. 17859

    Comparison of RPA2 dynamics in WT, <i>Cdk2</i><sup><i>T160A</i></sup>, <i>and Cdk2</i><sup><i>−/−</i></sup> spermatocytes. by Nathan Palmer (264897)

    Published 2020
    “…Data are presented as individual foci counts for WT (orange bars, N = 90 for early-pachytene and mid-pachytene stages), <i>Cdk2</i><sup><i>T160A</i></sup> (blue bars, N = 50 for early-pachytene and mid-pachytene stages), and <i>Cdk2</i><sup><i>−/−</i></sup> (gray bars, N = 50 for pachytene-like stage). …”
  20. 17860

    Image 3_Vitamin D supplementation during intensive care unit stay is associated with improved outcomes in critically Ill patients with sepsis: a cohort study.jpeg by Caifeng Li (3912883)

    Published 2025
    “…</p>Methods<p>We conducted a retrospective cohort study using data from MIMIC-IV database, a publicly available database containing clinical information on patients admitted to the ICU at Beth Israel Deaconess Medical Center (BIDMC) from 2008 to 2019. …”